Posts by: Patricia Silva, PhD

Patricia Silva, PhD

Patrícia holds her PhD in Medical Microbiology and Infectious Diseases from the Leiden University Medical Center in Leiden, The Netherlands. She has studied Applied Biology at Universidade do Minho and was a postdoctoral research fellow at Instituto de Medicina Molecular in Lisbon, Portugal. Her work has been focused on molecular genetic traits of infectious agents such as viruses and parasites.

June 16, 2015November 5, 2015

Lung Transplantation Associated with Good Survival Rates in Canadian Patients with Cystic Fibrosis

Cystic Fibrosis, News

A team led by researchers at St. Michael’s Hospital and the University of Toronto recently revealed that cystic fibrosis (CF) patients in Canada who undergo lung transplantation have good overall survival ... Read more

June 11, 2015November 9, 2015

New Potential Biomarkers for COPD Activity in Patients

COPD, News

A study recently published in the journal Respiratory Research proposes new potential biomarkers for chronic obstructive pulmonary disease (COPD) activity in patients. The study is entitled “Accelerated extracellular matrix turnover ... Read more

June 10, 2015November 6, 2015

Bronchiectasis Patients Found to Have a Sedentary Lifestyle in New Study

Bronchiectasis, News

A new study published in the journal BMC Pulmonary Medicine revealed that patients with bronchiectasis tend to have an inactive, sedentary lifestyle. The study is entitled “Sedentary behavior and physical ... Read more

June 8, 2015November 5, 2015

Vertex, Parion Collaboration to Advance Development of Potential Therapeutic Strategy for CF, Other Pulmonary Disorders

Cystic Fibrosis, News

Vertex recently announced a collaboration with Parion Sciences with the goal of developing investigational epithelial sodium channel (ENaC) inhibitors as potential therapies for cystic fibrosis (CF) and other pulmonary disorders. CF is ... Read more

June 5, 2015November 6, 2015

New Study Offer Insights Into a Molecular Pathway Underlying Lung Diseases

Asthma, News

A new study led by researchers at the Centenary Institute and the University of Sydney in Australia recently revealed a molecular pathway important in the development of lung diseases. The ... Read more

June 4, 2015November 5, 2015

Model to Predict IPF Mortality Used Successfully in Systemic Sclerosis-Associated Interstitial Lung Disease

Idiopathic Pulmonary Fibrosis, News

Researchers at the University of British Columbia in Canada recently reported that mortality prediction models used in patients with idiopathic pulmonary fibrosis (IPF) can also be employed to assess short-term ... Read more

June 2, 2015June 2, 2015

Opdivo (Nivolumab) Treatment Found to Offer Higher Overall Survival in Patients With Non-Small Cell Lung Cancer

Lung Cancer, News

Promising data on a Phase III trial (NCT01673867) to assess the safety and efficacy of nivolumab in the treatment of non-squamous non-small cell lung cancer (NSCLC) was recently presented at ... Read more

May 28, 2015November 6, 2015

UC Davis Researchers Propose Statins as an Inhaler Therapy for Asthma Treatment

Asthma, News

Researchers at the University of California, Davis (UC Davis) recently demonstrated that statin-based medication can be used to treat asthma as an inhaler formulation. The finding was published in the ... Read more

May 25, 2015November 9, 2015

Novartis Reveals Promising Results on Phase III Trials for Two Therapeutic Drugs against COPD

COPD, News

Novartis recently announced encouraging positive results on two of its pivotal Phase III clinical trial programs, the EXPEDITION program to assess the efficacy of QVA149 (indacaterol/glycopyrronium bromide) and the GEM program ... Read more

May 21, 2015November 5, 2015

New Insights into the Defective Protein Linked to Cystic Fibrosis

Cystic Fibrosis, News

Researchers at the National Health Institute, Doutor Ricardo Jorge and the University of Lisboa in Portugal recently published in the journal Science Signaling new insights into the processing of the ... Read more